UBS has lowered its target for Vivendi following its recent split. BOURSORAMA, acting solely as a distribution channel, emphasizes that the analysis is provided "as is" without any warranties, and the opinions expressed do not reflect its views. The institution maintains a conflict of interest management policy to ensure objectivity in its investment recommendations.